- Home
- EXEL vs TTMI Comparison
EXEL vs TTMI Comparison
Compare EXEL & TTMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | TTMI |
|---|---|---|
| Founded | 1994 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 12.0B |
| IPO Year | 2000 | 2000 |
Fundamental Metrics
Financial Performance| Metric | EXEL | TTMI |
|---|---|---|
| Price | $59.01 | $125.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 4 |
| Target Price | $46.50 | ★ $127.25 |
| AVG Volume (30 Days) | 2.2M | ★ 2.6M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.95 | ★ 211.11 |
| EPS | ★ 1.60 | 1.24 |
| Revenue | $452,477,000.00 | ★ $2,906,345,000.00 |
| Revenue This Year | $13.61 | $18.60 |
| Revenue Next Year | $13.13 | $16.91 |
| P/E Ratio | ★ $37.20 | $93.93 |
| Revenue Growth | N/A | ★ 18.98 |
| 52 Week Low | $33.76 | $45.73 |
| 52 Week High | $59.72 | $223.83 |
Technical Indicators
Market Signals| Indicator | EXEL | TTMI |
|---|---|---|
| Relative Strength Index (RSI) | 65.94 | 42.90 |
| Support Level | $54.30 | $87.36 |
| Resistance Level | N/A | $129.51 |
| Average True Range (ATR) | 1.49 | 7.06 |
| MACD | 0.60 | 0.44 |
| Stochastic Oscillator | 97.76 | 32.09 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About TTMI TTM Technologies Inc.
TTM Technologies Inc manufactures technology products, including mission systems, RF components, RF/microwave assemblies, and advanced interconnect products such as PCBs and substrates. It operates through three segments: A&D, Commercial, and RF&S Components. The A&D segment supports aerospace and defense missions with PCBs, assemblies, microelectronics, and integrated systems. The Commercial segment, generating the majority of revenue, serves automotive, medical, industrial, and data center markets. The RF&S Components segment provides TTM-designed RF components and COTS products. The Company's revenues come from PCBs, engineered systems, and long-term contracts for intelligence, surveillance, and communications solutions.